Meibotan Serenocard Heart care supplement#India First Probiotics Blend 35 Billion formulation Scientifically designed by CSIR-IMTECH I Control Cardiovascular diseases 1gm X 15 Sachet Blueberry Flavour (Men & Women)

About this item

• Control Blood pressure regulation
• Maintain Cholesterol & LDL Levels
• Serenocard is a pre-probiotic composition scientifically designed by CSIR-IMTECH focusing on the rebalancing the structural and functional changes in gut microbiota favouring prevention of cardiovascular diseases along with maintaining its immune homeostasis.
• The gut microbiota is mechanistically linked to systemic inflammation and endothelial function.
• Lactiplantibacillus plantarum improves endothelial function for both conduit and resistance vessels by increasing nitric oxide bioavailability and concurrently reducing systemic inflammation, as measured by brachial artery flow-mediated dilation.
• Probiotic Lactiplantibacillus plantarum and Streptococcus thermophilus enhances nitric oxide production and enhanced nitric oxide synthase (eNOS) activity in endothelial cells for efficacious endothelial function.
• Increased Gram-negative bacteria, lipopolysaccharide (LPS) levels compromise the cardiovascular function and increase the CVD risk. Probiotic Lacticaseibacillus rhamnosus and Prebiotic Inulin plays a significant role in reduction of LPS levels thereby mitigating the CVD risk.

• Limosilactobacillus reuterii and Lactobacillus acidophilus lowers the levels of inflammation biomarkers TNF-α, IL-6, IL-8 thereby reducing the CVD risk.
• Lactobacillus acidophilus increases HDL cholesterol levels thereby lowering the risk of heart disease and stroke.
• Bifidobacterium bifidum inhibit lipid peroxidation and ROS production and, as a result, may slow or even prevent the development of CVDs and other oxidative stress-related diseases. Saccharomyces cerevisiae and its metabolites shows beneficial effect in treatment of cardiovascular diseases.